D57.458

Clinical Causes: Genetic mutations affecting hemoglobin production, inherited from parents Combination of sickle-cell gene (HbS) and beta-thalassemia gene influences the severity Triggers such as infections, dehydration, extreme temperatures, or physical stress may precipitate crises

Key Symptoms: Severe episodes of pain, often in the chest, abdomen, joints, or bones Fatigue or weakness due to anemia Swelling in hands and feet Frequent infections Delayed growth or puberty in children Ulcers on the legs Jaundice (yellowing of the skin and eyes)

Diagnosis Path: Diagnosis involves blood tests including a complete blood count (CBC) to detect anemia, hemoglobin electrophoresis to identify hemoglobin types (HbS and abnormal forms), and genetic testing. Medical history and physical examination assist in understanding previous crises and associated complications. Imaging studies may be used to assess organ damage, especially after repeated crises.

Treatment Protocols: While there is no universal cure for sickle-cell thalassemia beta plus with crises, several management strategies focus on controlling symptoms and preventing complications: - **Pain management:** Use of analgesics during crises - **Blood transfusions:** Regular or as needed to reduce sickled cells and improve blood flow - **Medications:** Such as hydroxyurea, which can decrease the frequency of crises - **Infection prevention:** Vaccinations and antibiotics to reduce infection risks - **Folic acid supplements:** To support red blood cell production - **Bone marrow transplant:** A potential curative option in select cases - **Monitoring and managing complications:** Including organ damage, stroke, or leg ulcers Patients are encouraged to maintain regular medical care, stay hydrated, avoid extreme temperatures, and recognize early signs of crises to seek prompt medical attention.